Methods and Results— We conducted a randomized multicenter comparison of these 2 treatment strategies in patients with paroxysmal AF resistant to at least 1 antiarrhythmic drug.
2
本文对多非利特、 索他洛尔、 伊布利特等新的治疗心房颤动的药物的药理作用、临床研究情况作一介绍。
The pharmacologic action and clinical investigation of new anti-atrial fibrillation drugs, such as dofetilide, sotalol, ibutilide are reviewed in this paper.
The assessment comes as a U. S. Food and Drug Administration advisory panel mulls whether to recommend approval of the intravenous drug for atrial fibrillation (AF).
点击反馈